IDL Biotech AB share has been listed on Spotlight Stock Market since (26/6 2000) under the ticker (IDL B) and is traded through banks and stockbrokers.
In accordance with all regulations, IDL issues quarterly reports to the market and distributes the annual report to all shareholders. All this information is in Swedish.
The share holder’s annual meeting is usually held in Stockholm, and is announced accordingly.
2019-04-18 IDL Biotech first quarter report
2019-05-28 IDL Biotech Annual meeting
2019-08-22 IDL Biotech second quarter report
2019-10-17 IDL Biotech third quarter report
2020-02-20 IDL Biotech fourth quarter report and Year-end report 2019
CEO Charlotte Berg is interviewed in the latest podcast from SvD Börspluspod.
Interview with CEO Charlotte Berg
Börshajen has published an interview with Charlotte Berg, CEO at IDL Biotech.
Nomination Committe for IDL appointed
IDL Biotechs extra ordinary general meeting held on the 25th October 2018 decided to establish a nomination committee.
Interview with Charlotte Berg
On Saturday the 17th of November, the Swedish newspaper SvD, had an interview with the CEO, Charlotte Berg.